As we have said previously, after a series of disappointments, it is to be hoped that FY17 will be the bottom for the recent cycle of earnings, as Flexonics markets recover and Aerospace volumes transition towards the new commercial programmes. These results again support that view and with a generally improving outlook in the previously challenging markets, we increase our target price to 248p and remain at Hold.